Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
06/2001
06/14/2001WO2001042199A1 Amidinophenylpyruvic acid derivative
06/14/2001WO2001030791A3 Method for the preparation of 2',3'-didehydro-2',3'-dideoxycytidine derivatives
06/14/2001WO2001028537A3 Bissulfonamide derivatives as enzyme inhibitors
06/14/2001US20010003750 Used as research tools in pharmacological, diagnostic studies and treatment of diseases in mammals in which 1L-beta-protease activity is implicated; antiinflammatory agent
06/14/2001US20010003732 Substituted phenyluracils
06/14/2001CA2733434A1 Caspase inhibitors and uses thereof
06/14/2001CA2393562A1 Detection of transmembrane potentials by optical methods
06/14/2001CA2390669A1 Nitro-sulfobenzamides
06/13/2001EP1106607A2 Uracil compounds and their use
06/13/2001EP1106210A2 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications
06/13/2001EP1105378A1 Quinazoline derivatives
06/13/2001EP1105377A1 Pyrimidinone derivatives for the treatment of atherosclerosis
06/13/2001EP1105372A1 Methoximinophenylacetic acid amides
06/13/2001EP1105359A1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions
06/13/2001EP0824527B1 Quinazoline derivatives
06/13/2001EP0824526B1 Quinazoline derivative
06/13/2001EP0824525B1 Quinazoline derivatives
06/13/2001EP0656892B1 Herbicidal 2- (4-heterocyclic-phenoxymethyl)phenoxy]-alkanoates
06/13/2001CN1299282A Vitronectin receptor antagonists
06/12/2001US6245912 Process for making N-alkyl bis(2-pyridyl) sulfenimides
06/12/2001US6245773 Benign prostatic hyperplamia; reduction of intraocular pressure
06/12/2001US6245770 Fungicidal pyrimidinones
06/12/2001US6245763 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
06/12/2001US6245715 Substituted iminoalkoxy-phenyluracils, the production and use thereof as herbicides
06/12/2001US6245714 Substituted phenyl uracils
06/12/2001CA2080917C New pharmacologically active catechol derivatives
06/07/2001WO2001040196A1 2-amino-5,6-dihalo-3,4-dihydroquinazolines with blood platelet reducing properties
06/07/2001WO2001040187A2 Compound having effect of promoting neuron differentiation
06/07/2001WO2001014344A3 Polycyclic pyrimidine-2,4(1h, 3h)-dione with functionalized alkyl radicals in 1- and/or 3-position, method for the production thereof and pharmaceutical preparations
06/07/2001CA2388239A1 Neuroprotective agents and methods related thereto
06/07/2001CA2327575A1 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications
06/06/2001EP1104754A1 Novel sulfonyl derivatives
06/06/2001EP1104410A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists
06/06/2001EP1104300A2 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
06/06/2001CN1298406A Condensed thienopyrimidines with phosphodiesterase-V inhibiting action
06/06/2001CN1298396A N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
06/06/2001CN1066720C Process for producing pharmaceutically active CNS compounds
06/06/2001CN1066719C Process for producing pharmaceutically active CNS compounds
06/06/2001CN1066718C Substituted aryloxy-alkyl diamines and its producing process and use
06/05/2001US6242634 Pyrimidin-4-one derivatives, their use, intermediates for their production, and processes for producing these intermediates
06/05/2001US6242612 Multistage reaction of forming pyrazoles as kinase and cox-2 enzyme inhibitors
06/05/2001US6242601 Heterocyclic sulfamides
06/05/2001US6242495 Compounds and compositions for delivering active agents
06/05/2001US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation
06/05/2001US6242455 Inhibiting a matrix metalloprotease associated disease
06/05/2001US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
05/2001
05/31/2001WO2001038315A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
05/31/2001WO2001038314A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
05/31/2001WO2001038313A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p39 kINASE INHIBITORS
05/31/2001WO2001038312A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
05/31/2001WO2001038311A2 Pyrimidine derivatives as selective inhibitors of cox-2
05/31/2001WO2001037837A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS
05/31/2001WO2001037826A1 Npyy5 antagonists
05/31/2001WO2000075172A3 Factor viia inhibitors
05/31/2001WO1999064041A9 Multibinding agents that modulate nmda receptors
05/31/2001US20010002400 Administering an antifungal agent
05/31/2001US20010002398 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98%
05/31/2001CA2395049A1 Pyrimidine derivatives as selective inhibitors of cox-2
05/31/2001CA2386955A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
05/30/2001EP1102756A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
05/30/2001EP1102750A1 Amide derivatives useful as inhibitors of the production of cytokines
05/30/2001EP1102742A2 Compounds and compositions for delivering active agents
05/30/2001EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors
05/30/2001EP0815106B1 3-aryluracils and intermediates for their preparation
05/30/2001CN1297447A Anti-viral pyrimidine derivs
05/30/2001CN1297441A Heterocyclically substd. amides used as calpain inhibitors
05/30/2001CN1297432A Substd. amides, their production and their use
05/30/2001CN1297350A Agents for relieving side effects
05/30/2001CN1296945A Process for preparing aminopyrimidine sulfate by reducing pyrimidine derivative containing nitroso
05/29/2001US6239306 Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulations
05/29/2001US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials
05/29/2001US6239151 Compounds as inhibitor of tumor necrosis factor alpha release
05/29/2001US6239138 Vitronectin receptor antagonist
05/29/2001US6239074 Substituted 3-phenyluracils
05/29/2001CA2053339C Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines
05/25/2001WO2001036403A1 Urea derivatives as anti-inflammatory agents
05/25/2001WO2001036394A1 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline to prevent development of colorectal cancer
05/25/2001WO2001036393A1 Hydroxamic acid derivatives
05/25/2001WO2001036392A1 [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinylamino]acetamide derivatives, process for producing the same, medicinal compositions containing the same and intermediate of these compounds
05/25/2001WO2001036391A1 Thiamin disulfide derivatives
05/25/2001WO2001036376A1 Novel phenylalanine derivatives
05/25/2001WO2001000591A3 Method for producing 4,6-dichloropyrimidine
05/25/2001WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/25/2001CA2391396A1 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline to prevent development of colorectal cancer
05/25/2001CA2390259A1 ¬5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinylamino|acetamide derivatives, process for preparing the same, medicinal compositions containing the same, and intermediate of these compounds
05/23/2001EP1101761A2 Process for producing 3-phenyluracil compounds
05/23/2001EP1101760A1 Di- or tri-fluoromethanesulfonyl anilide derivatives, process for the preparation of them and herbicides containing them as the active ingredient
05/23/2001EP1100790A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them
05/23/2001EP1100789A1 Substituted benzoylcyclohexandiones
05/23/2001EP1100788A1 Substituted quinazoline derivatives
05/23/2001EP1100787A1 Lipid-lowering quinazoline derivative
05/23/2001EP1100786A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
05/23/2001EP1100785A1 Substituted cyclohexylaminopyrimidines
05/23/2001EP1100766A1 Crosslinkable liquid crystalline compounds
05/23/2001EP1100519A1 Multibinding agents that modulate nmda receptors
05/23/2001EP1100506A1 Integrin receptor antagonists
05/23/2001EP1100505A1 A PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A iNOS INHIBITOR
05/23/2001EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders
05/23/2001EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications
05/23/2001EP1100498A1 Heterocyclic sulphonamide derivatives